The mice that received ACT of CD44high CD8 T cells from FLT3L-treated OT-1 mice showed tumor regression, while untreated mice and those that received ACT from vehicle control mice did not (Fig. 3B, Additional file 1: Figure S10). Here, CD8A is linked to neoplasm.